1. FP379ERYTHROFERRONE PREDICTS MORTALITY AND CARDIOVASCULAR EVENTS IN CKD AND IN HEMODIALYSIS PATIENTS: A TWO COHORTS STUDY. (13th June 2019) Authors: Spoto, Belinda; Pizzini, Patrizia; Torino, Claudia; Leonardis, Daniela; Cutrupi, Sebastiano; Tripepi, Giovanni; Lo, Larry; Devalaraja, Matt; Mallamaci, Francesca; Kakkar, Rahul; Zoccali, Carmine Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10289 (29th May 2021) Authors: Ridker, Paul M; Devalaraja, Matt; Baeres, Florian M M; Engelmann, Mads D M; Hovingh, G Kees; Ivkovic, Milana; Lo, Larry; Kling, Douglas; Pergola, Pablo; Raj, Dominic; Libby, Peter; Davidson, Michael Journal: Lancet Issue: Volume 397:Issue 10289(2021) Page Start: 2060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis. (September 2020) Authors: Chen, Xuguang; Gui, Chengcheng; Grimm, Jimm; Huang, Ellen; Kleinberg, Lawrence; Lo, Larry; Sciubba, Daniel; Khan, Majid; Redmond, Kristin J. Journal: Radiotherapy and oncology Issue: Volume 150(2020) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗